Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral allicin tablets for minor recurrent aphthous stomatitis
IRCT20241208063988N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of allicin in Minor aphthous stomatitis (MiRAS), sponsored by Mazandaran University of Medical Sciences. Started Dec 2024; status: completed.
02
Drugs
allicin
03
Conditions
Minor aphthous stomatitis (MiRAS)
Beyond the preview
Go deeper on IRCT20241208063988N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241208063988N1.